There was a significant difference (Figure 3D) between binding of β-gal loaded DimerX by CD8 positive T cells isolated from mice cured from CT26.CL25 tumors and from naïve CT26.CL25 tumor bearing mice. The gene discussed is CD8A; the disease is neoplasm.